PRINCETON, N.J., Sept. 19, 2023 CytoSorbents Corporation , a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat cytokine storm and deadly.
Cytosorbents (CTSO) Announces Kathleen P Bloch To Resume as Full-Time Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cytosorbents Co. (NASDAQ:CTSO – Free Report) – Investment analysts at HC Wainwright boosted their FY2023 earnings per share (EPS) estimates for Cytosorbents in a report released on Wednesday, August 2nd. HC Wainwright analyst S. Lee now anticipates that the medical research company will post earnings per share of ($0.59) for the year, up from their […]
HC Wainwright reaffirmed their buy rating on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report report published on Wednesday morning, Benzinga reports. The brokerage currently has a $5.50 price objective on the medical research company’s stock. HC Wainwright also issued estimates for Cytosorbents’ FY2023 earnings at ($0.59) EPS, Q1 2024 earnings at […]
Cytosorbents Co (NASDAQ:CTSO) to Post FY2023 Earnings of ($0 59) Per Share, HC Wainwright Forecasts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.